Extended cyclosporine-A - Treatment for severe chronic urticaria

Harefuah

Volumn 145, Issue 6, 2006, Pages

  Kessel, Aharon ^a   Toubi, Elias ^a  

^a BNAI ZION MEDICAL CENTER   (Israel)

Author keywords

Cyclosporine A; Urticaria

Indexed keywords

CYCLOSPORIN A; PREDNISONE; CYCLOSPORIN; DERMATOLOGICAL AGENT;

ADULT; ARTICLE; CHRONIC URTICARIA; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DISEASE DURATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG SAFETY; HIRSUTISM; HUMAN; PERIPHERAL NEUROPATHY; REMISSION; CHRONIC DISEASE; CLINICAL TRIAL; MIDDLE AGED; TREATMENT OUTCOME; URTICARIA;

ADULT; CHRONIC DISEASE; CYCLOSPORINE; DERMATOLOGIC AGENTS; HUMANS; MIDDLE AGED; PREDNISONE; TREATMENT OUTCOME; URTICARIA;

EID: 33746826161     PISSN: 00177768     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Draberova L, Cyclosporin A inhibits rat mast cell activation. Eur J Immunol, 1990; 20: 1469-73.
2. Marone G, Triggiani M, Cirillo R & al, Cyclosporin A inhibits the release of histamine and peptide leukotriene C4 from human lung mast cells. Ric Clin Lab, 1988; 18: 53-9.
3. Stellato C, de Paulis A, Ciccarelli A & al, Anti-inflammatory effect of cyclosporin A on human skin mast cells. J Invest Dermatol, 1992; 98: 800-4.
4. Grattan CE, Wallington TB, Warin RP & al, A serological mediator in chronic idiopathic urticaria - a clinical, immunological and histological evaluation. Br J Dermatol, 1986; 114: 583-90.
5. Hide M, Francis DM, Grattan CE & al, Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med, 1993; 328: 1599-604.
6. Niimi N, Francis DM, Kermani F & al, Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria. J Invest Dermatol, 1996; 106: 1001-6.
7. Leznoff A & Sussman GL, Syndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: a study of 90 patients. J Allergy Clin Immunol, 1989; 84: 66-71.
8. O'Donnell BF, O'Neill CM, Francis DM & al, Human leucocyte antigen class II associations in chronic idiopathic urticaria. Br J Dermatol, 1999; 140: 853-8.
9. Mekori YA, Giorno RC, Anderson P & Kohler PF, Lymphocyte subpopulations in the skin of patients with chronic urticaria. J Allergy Clin Immunol, 1983; 72: 681-4.
10. Elias J, Boss E & Kaplan AP, Studies of the cellular infiltrate of chronic idiopathic urticaria: prominence of T-lymphocytes, monocytes, and mast cells. J Allergy Clin, 1986; 78: 914-8.
11. Ying S, Kikuchi Y, Meng Q & al, TH1/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reaction. J Allergy Clin Immunol, 2002; 109: 694-700.
12. Toubi E, Adir-Shani A, Kessel A & al, Immune aberrations in B and T lymphocytes derived from chronic urticaria patients. J Clin Immunol, 2000; 20: 371-8.
13. Kessel A, Bishara R, Amital A & al, Increased plasma levels of matrix metalloproteinase-9 are associated with the severity of chronic urticaria. Clin Exp Allergy, 2005; 35: 221-5.
14. Hidvegi B, Nagy E, Szabo T & al, Correlation between T-cell and mast cell activity in patients with chronic urticaria. Int Arch Allergy Immunol, 2003; 132: 177-82.
15. Breneman D, Bronsky AK & Bruce S, Cetirizine and astemisone therapy for chronic urticaria: a double-blind, placebo-controlled, comparative trial. J Am Acad Dermatol, 1995; 33: 192-8.
16. Fradin MS, Ellis CN, Goldfarb MT & Voorhees JJ, Oral cyclosporine for severe chronic idiopathic urticaria and angioedema. J Am Acad, 1991; 25: 1065-7.
17. Toubi E, Blant A, Kessel A & Golan TD, Low-dose cyclosporin A in the treatment of severe chronic idiopathic urticaria. Allergy, 1997; 52: 312-6.
18. Grattan CE, O'Donnell BF, Francis DM & al, Randomized double-blind study of cyclosporin in chronic 'idiopathic' urticaria. Br J Dermatol, 2000; 143: 365-72.
19. Greaves MW, Chronic idiopathic urticaria. Curr Opin Allergy Clin Immunol, 2003; 3: 363-8.
20. Toubi E, Bamberger E & Kessel A, Prolonged cyclosporin-A treatment for severe chronic urticaria. Allergy, 2003; 58: 535-6.